Duofilm Plantar Patch
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
- Titolare
- Haleon US Holdings LLC
- NPN o DIN-HM
- 02243332
- Stato
- Licenza non attiva
- Data della licenza
- 24 novembre 2009
- Data di revisione
- 22 febbraio 2017
- Forma
- Plâtre
- Via di somministrazione
- Topique
- Tipo di domanda
- DIN de transition
L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.
Composizione
Composizione medicinale non indicata.
Ingredienti non medicinali
Rubber, Polybutene, Dioxyde de titane, Rosin Ester
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes et enfants | minimum : 3 ans | 1 patch | 48 heures |
Usi autorizzati in Canada
For the removal of plantar warts on the bottom of the feet.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Known Adverse Reactions : Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as: rare (greater than or equal to 1/10000 to less than 1/1000). Post-marketing data Immune system disorders Rare: Application site hypersensitivity including inflammation. Skin and subcutaneous tissue disorders Rare: Application site reaction (including pain, irritation, burning sensation, erythema, and pruritus). Application site discoloration/skin discoloration. Exposure to healthy skin can lead to application site blistering and skin exfoliation (see WARNINGS AND PRECAUTIONS). Interactions DUOFILM® may increase the absorption of other topically applied medicines. Therefore, concomitant use of DUOFILM® and other topical medicines on the treated area should be avoided.
Testo originale in inglese.
Cautions and Warnings : DUOFILM® is for external use only. DUOFILM® is not recommended in patients with a known sensitivity or allergy to any of the ingredients. DUOFILM® may cause eye irritation. Avoid contact with eyes and other mucous membranes. In case of accidental contact with the eyes or other mucous membranes, flush with water for 15 minutes. Avoid exposure to healthy skin. DUOFILM® may cause skin irritation. If undue skin irritation develops, treatment should be discontinued. Consider alternative treatments if warts cover a large area of the body (more than 5 cm²) due to the potential risk of salicylate toxicity. DUOFILM® is not recommended in patients with peripheral neuropathy except under the supervision of a physician. Oral salicylates have been associated with Reye's syndrome and hence there is a theoretical risk with topical salicylates. Therefore, use is not advised in children or teenagers during or immediately after chickenpox, influenza, or other viral infections. Patients should be advised not to inhale the vapour. It has been reported that salicylates are excreted via breast milk. Patients should be advised to consult a physician if discomfort persists. Pregnancy and Lactation Pregnancy The safety of DUOFILM® during human pregnancy has not been established. Studies in animals given salicylic acid orally demonstrated embryo-toxicity at high doses. DUOFILM® is not recommended during pregnancy. Lactation Salicylates are excreted in human milk. DUOFILM® is not recommended during lactation. If used or administered during lactation, care should be taken to avoid contact with the breast area in order to avoid accidental ingestion by the infant.
Testo originale in inglese.
Contra-Indications : Do not use DUOFILM® if you have diabetes or poor blood circulation. Do not use DUOFILM® on open wounds, irritated or reddened skin or any area that is infected. Do not use DUOFILM® on moles, birthmarks, genital warts, warts on the face or mucous membranes, warts with hair growing from them, red edges, or unusual colour.
Testo originale in inglese.
Fonte
Scheda ufficiale Health Canada, licenza 02243332
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.